Home/Filings/4/0001610717-24-000011
4//SEC Filing

Reider Paul 4

Accession 0001610717-24-000011

CIK 0001512762other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 5:13 PM ET

Size

5.4 KB

Accession

0001610717-24-000011

Insider Transaction Report

Form 4
Period: 2024-01-02
Reider Paul
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-02+160,000160,000 total
    Exercise: $3.14Exp: 2034-01-02Common Stock (160,000 underlying)
Footnotes (1)
  • [F1]1/48th of the total number of shares subject to the option shall vest in successive, equal monthly installments measured from January 2, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file

Issuer

Coherus BioSciences, Inc.

CIK 0001512762

Entity typeother

Related Parties

1
  • filerCIK 0001970033

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:13 PM ET
Size
5.4 KB